Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of Glucagon-Induced Ghrelin Suppression
NCT00929812Phase 3Unknown
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jun 2006
- Primary completion
- Jan 2008
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of glucagon in obesity, type 1 diabetes mellitus (T1D), sponsored by Charité – Universitätsmedizin Berlin. Status: unknown.
02
Drugs
glucagon
03
Conditions
obesitytype 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00929812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00929812.